UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/5/2025 | $39.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 12/6/2023 | $29.00 | Neutral | UBS |
| 11/13/2023 | $30.00 | Neutral → Buy | BofA Securities |
| 5/9/2023 | $25.00 → $27.00 | Underperform → Neutral | BofA Securities |
| 2/8/2023 | $25.00 → $26.50 | Mkt Perform → Outperform | Keefe Bruyette |
| 1/9/2023 | $24.50 | Neutral → Underperform | Credit Suisse |
| 9/6/2022 | $27.00 | Overweight → Neutral | JP Morgan |
| 8/18/2022 | $25.00 | Neutral → Underperform | BofA Securities |
144 - Enact Holdings, Inc. (0001823529) (Subject)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
10-Q - Enact Holdings, Inc. (0001823529) (Filer)